Evidence map›Paper›PMID 39816698›Full record

ArticleSurgery open science2025

Therapeutic efficacy and prognostic indicators in re-resection for recurrent hepatocellular carcinoma: Insights from a retrospective study.

Qi Fan, Pengcheng Wei, Delin Ma, Qian Cheng, Jie Gao, Jiye Zhu, Zhao Li

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Surgery open science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Qi FanDepartment of General Surgery, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China.
Pengcheng WeiDepartment of Hepatobiliary Surgery, Peking University People's Hospital, Beijing, China.
Delin MaDepartment of Hepatobiliary Surgery, Peking University People's Hospital, Beijing, China.
Qian ChengDepartment of Hepatobiliary Surgery, Peking University People's Hospital, Beijing, China.
Jie GaoDepartment of Hepatobiliary Surgery, Peking University People's Hospital, Beijing, China.
Jiye ZhuDepartment of Hepatobiliary Surgery, Peking University People's Hospital, Beijing, China.
Zhao LiDepartment of Hepatobiliary Surgery, Peking University People's Hospital, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aims: To evaluate the efficacy of re-resection in recurrent hepatocellular carcinoma (rHCC), identify prognostic factors, and provide clinical guidance. Methods: A retrospective analysis was conducted on 130 rHCC patients undergoing re-resection and 60 primary HCC patients undergoing initial hepatectomy at Peking University People's Hospital (2014-2022). Disease-free survival (DFS) and overall survival (OS) were compared. Prognostic factors were identified using univariate and multivariate COX regression analyses. Results: Baseline characteristics were comparable between groups ( Conclusions:

Indexed as

Immune microenvironmentPrognosisRecurrent hepatocellular carcinomaRe-resectionSurvival analysis

Identifiers

PMID39816698
PMCPMC11733202

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.